IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer.

作者: Gerrit Peters , Silvia Gongoll , Cord Langner , Michael Mengel , Pompiliu Piso

DOI: 10.1007/S00428-003-0856-5

关键词:

摘要: Insulin-like growth factors (IGF-1 and IGF-2) the IGF-1 membrane receptor (IGF-1R) have been found to play a critical role in carcinogenesis of several tumors, among them colorectal cancer (CRC). To study prognostic impact these molecules, total number 713 cases CRC were examined for expression IGF-1, IGF-2, IGF-1R. The results correlated with other clinicopathological data clinical follow-up. was noted 53 (7.5%), IGF-2 88 (12.6%), IGF-1R 698 (99.6%) cases. There significant associations between two (P<0.00001), Ki-67 proliferation activity (P<0.05), tumor stage (P<0.005). positivity significantly worse outcome (P<0.005) only univariate, but not multivariate, survival analysis. A similar trend obtained patients IGF-1-positive CRC, reached statistical significance limited stages (pT1/pT2; P<0.01). Although synchronous subset is consistent an auto-/paracrine loop cell autostimulation, effect seems be value. However, identification IGF-positive might beneficial predictive reasons, as new molecular therapeutic approaches are aimed at IGF system related pathways.

参考文章(37)
Roberto Labianca, Maria Adelaide Pessi, Giuseppina Zamparelli, Treatment of colorectal cancer. Current guidelines and future prospects for drug therapy. Drugs. ,vol. 53, pp. 593- 607 ,(1997) , 10.2165/00003495-199753040-00005
R W Furlanetto, S E Harwell, K K Frick, Insulin-like growth factor-I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro. Molecular Endocrinology. ,vol. 8, pp. 510- 517 ,(1994) , 10.1210/MEND.8.4.8052269
Silvia Gongoll, Gerrit Peters, Michael Mengel, Pompiliu Piso, Jürgen Klempnauer, Hans Kreipe, Reinhard von Wasielewski, Prognostic significance of calcium-binding protein S100A4 in colorectal cancer Gastroenterology. ,vol. 123, pp. 1478- 1484 ,(2002) , 10.1053/GAST.2002.36606
H. Bleiberg, Colorectal cancer—Is there an alternative to 5-FU? European Journal of Cancer. ,vol. 33, pp. 536- 541 ,(1997) , 10.1016/S0959-8049(96)00481-9
Herbert Yu, Thomas Rohan, Role of the insulin-like growth factor family in cancer development and progression Journal of the National Cancer Institute. ,vol. 92, pp. 1472- 1489 ,(2000) , 10.1093/JNCI/92.18.1472
F. Rozen, X.-F. Yang, H. Huynh, M. Pollak, Antiproliferative Action of Vitamin D-Related Compounds and Insulin-Like Growth Factor-Binding Protein 5 Accumulation Journal of the National Cancer Institute. ,vol. 89, pp. 652- 656 ,(1997) , 10.1093/JNCI/89.9.652
R Lammers, G Carpenter, M Limardo, A Ullrich, P D Phillips, A M Soderquist, R Baserga, Z Pietrzkowski, Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors. Cell Growth & Differentiation. ,vol. 3, pp. 199- 205 ,(1992)
Wenbiao Liu, Lee M. Ellis, Brian Zebrowski, Yoshito Akagi, Keping Xie, Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Research. ,vol. 58, pp. 4008- 4014 ,(1998)
Rubin R, Baserga R, Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Laboratory Investigation. ,vol. 73, pp. 311- 331 ,(1995)